Immunotherapy with ponezumab for probable cerebral amyloid angiopathy.
Leurent C, Goodman JA, Zhang Y, He P, Polimeni JR, Gurol ME, Lindsay M, Frattura L, Sohur US, Viswanathan A, Bednar MM, Smith EE; Ponezumab Trial Study Group; Greenberg SM.
Leurent C, et al.
Ann Clin Transl Neurol. 2019 Mar 18;6(4):795-806. doi: 10.1002/acn3.761. eCollection 2019 Apr.
Ann Clin Transl Neurol. 2019.
PMID: 31020004
Free PMC article.